Immunotherapy plus an investigational cancer drug improves anti-tumor effects
An investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific kind of cancer cell, a research team at Duke and Harvard have found.
Nov 8, 2023
0
1